3-硝基-苯甲酸-(2-羟基-苯胺) | 344263-66-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-硝基-苯甲酸-(2-羟基-苯胺)
• 英文名称: N-(2-hydroxyphenyl)-3-nitro-benzamide
• 英文别名: N-(2-Hydroxyphenyl)-3-nitrobenzamide
• CAS: 344263-66-7
• 化学式: C₁₃H₁₀N₂O₄
• 分子量: 258.233
• InChiKey: GJTFCBSCZNMKPM-UHFFFAOYSA-N

物化性质

• 熔点：
  206 °C
• 沸点：
  354.8±27.0 °C(Predicted)
• 密度：
  1.446±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  95.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-硝基-苯甲酸-(2-羟基-苯胺) 在 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 生成 2-(3-硝基苯基)-1,3-苯并恶唑
  参考文献：
  名称：

  2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors

  摘要：

  A novel class of 2,3-dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acids are described as inhibitors of the endo-beta-glucuronidase heparanase. Several of the compounds, for example, 2-[4-propylamino-5-[5-(4-chloro)phenyl-benzoxazol-2-yl]phenyl]-2,3-dihydro-1,3-dioxo-IH-isoindole-5-carboxylic acid (9c), display potent heparanase inhibitory activity (IC50 200-500nM) and have high selectivity ( > 100-fold) over human beta-glucuronidase. They also show anti-angiogenic effects. Such compounds should serve as useful biological tools and may provide a basis for the design of novel therapeutic agents. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.086
• 作为产物：
  描述：

  间硝基苯甲酸 在 草酰氯 、 N,N-二甲基甲酰胺 作用下， 以 四氢呋喃 为溶剂， 生成 3-硝基-苯甲酸-(2-羟基-苯胺)
  参考文献：
  名称：

  2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors

  摘要：

  A novel class of 2,3-dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acids are described as inhibitors of the endo-beta-glucuronidase heparanase. Several of the compounds, for example, 2-[4-propylamino-5-[5-(4-chloro)phenyl-benzoxazol-2-yl]phenyl]-2,3-dihydro-1,3-dioxo-IH-isoindole-5-carboxylic acid (9c), display potent heparanase inhibitory activity (IC50 200-500nM) and have high selectivity ( > 100-fold) over human beta-glucuronidase. They also show anti-angiogenic effects. Such compounds should serve as useful biological tools and may provide a basis for the design of novel therapeutic agents. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.086

文献信息

• Access to C4-arylated benzoxazoles from 2-amidophenol through C–H activation
  作者：Kanchanbala Sahoo、Priyanka Pradhan、Niranjan Panda

  DOI：10.1039/d0ob00061b

  日期：——

  A Pd-catalyzed aerobic approach to access C4-aryl benzoxazoles by tandem C-H ortho-arylation and acid-mediated annulation of 2-amidophenol has been presented. The directing potential of the -NHCOR group over the -OH group was exploited for selective arylation adjacent to the amide group. Deuterium labeling experiments suggest that palladation predominantly occurs adjacent to the -NHCOR group and is

  提出了一种通过Pd催化的好氧方法，通过串联CH邻位芳基化和酸介导的2-酰胺基苯酚来获得C4-芳基苯并恶唑。利用-NHCOR基团相对于-OH基团的定向电位来进行与酰胺基团相邻的选择性芳基化。氘标记实验表明，触诊主要发生在-NHCOR基团附近，并且是苯并恶唑形成过程中的关键步骤。还完成了所得到的C4-芳基化苯并恶唑的一锅水解，以获取结构上具有挑战性的3-芳基氨基苯酚以用于进一步的应用。
• Synthesis of 4‐Alkenyl Benzoxazoles via Pd‐catalyzed <i>ortho</i> C−H Functionalization of 2‐Amidophenols
  作者：Niranjan Panda、Kanchanbala Sahoo

  DOI：10.1002/adsc.201801272

  日期：2019.2

  A one‐pot direct transformation to remotely C−H alkene functionalized 2‐aryl benzoxazoles from the reaction of amidophenol and electronically deficient olefin was reported. Control experiments confirm that the Pd‐catalyzed regioselective C−H activation/alkenylation occurs at the first step by leading to ortho‐alkenylated amidophenol; which subsequently underwent tandem intramolecular annulation to

  据报道，从酰胺基苯酚和电子缺陷烯烃的反应中，可以一锅直接转化为远程CH-H烯烃官能化的2-芳基苯并恶唑。对照实验证实，Pd催化的区域选择性CH活化/烯基化是通过导致邻链烯基化的氨基苯酚在第一步发生的。随后进行串联分子内环化，得到C4-烯基化的2-芳基苯并恶唑衍生物。
• Tingle; Williams, American Chemical Journal, 1907, vol. 37, p. 69
  作者：Tingle、Williams

  DOI：——

  日期：——
• Ransom, American Chemical Journal, 1900, vol. 23, p. 39
  作者：Ransom

  DOI：——

  日期：——
• SHOEB, H. A., EGYPT. J. CHEM., 1979, 22, N 3, 245-254
  作者：SHOEB, H. A.

  DOI：——

  日期：——